Colgate-Palmolive Company Q2 2026 Earnings Recap

Colgate-Palmolive shares edged down 0.3% following Q2 results as modest U.S. underperformance and category softness in Pet pressured sentiment despite broad-based global growth and solid margin management.

Key Takeaways

• Organic sales grew in 4 of 5 divisions and 3 of 4 categories, led by mid-single digit growth in emerging markets including India, Brazil, Mexico, and China.
• Hill's Pet Nutrition segment outpaced the soft pet category with 4% organic growth ex-private label disruption, though pricing was the main driver behind pet sales growth.
• U.S. business showed signs of weakness requiring targeted category and channel actions to improve market share and heightened brand investments in H2.
• Gross margins expanded before a modest tariff benefit; the company maintained profit and EPS growth amid significant cost inflation.
• Free cash flow rose 18% with $1.4 billion returned to shareholders, supporting financial discipline and shareholder returns.